US2016375010A1PendingUtilityA1
Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
Est. expirySep 19, 2031(~5.2 yrs left)· nominal 20-yr term from priority
Inventors:Andreas Fischer
A61P 25/36A61P 25/30A61P 25/04A61K 9/20A61K 31/485A61K 9/0056A61K 9/2054A61K 31/4748A61K 9/14A61K 9/2018A61K 9/2013A61K 9/2077A61K 9/006A61K 9/2095
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
There is provided pharmaceutical compositions for the treatment of e.g. opioid dependency comprising microparticles of a pharmacologically-effective amount of buprenorphine, or a pharmaceutically-acceptable salt thereof, in associative admixture with particles comprising a weak acid, or particles comprising weakly-acidic buffer forming materials. The composition may further comprise a disintegrant and/or particles of a pharmacologically-effective amount of naloxone, or a pharmaceutically-acceptable salt thereof. The compositions are useful in the treatment of opioid dependency/addiction and/or pain.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition comprising microparticles of a pharmacologically-effective amount of buprenorphine, or a pharmaceutically-acceptable salt thereof, in associative admixture with particles comprising a weak acid, or particles comprising weakly-acidic buffer forming materials.
Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.